Hon Steve Irons MP, recently dropped by to present Epichem CEO Colin La Galia and the team an Australian Export & Investment Award. Epichem is one of only 8 companies recognised for incredible resilience in the the face of major COVID disruptions in 2020.
Epichem is proud to announce a new partnership with Sanoosa, a computational drug discovery company, to develop a novel compound series active and selective against cancers caused by RAS mutations.
Epichem is pleased to partner with another Perth WA based research group, PYC Therapeutics, on developing a new treatment for Retinitis Pigmentosa a devastating genetic disorder which causes loss of vision.
Epichem will benefit from mentoring, facilitated market engagement, profile raising, staff development, multi sector opportunities and expand its networks in the program.
Epichem has entered into a license agreement with Thermaquatica for the Oxidative Hydrothermal Dissolution (OHD) technology
• Epichem will research, develop and promote the novel, innovative, disruptive technology using Flow Reaction
• Epichem will continue to seek government and project grant funding to accelerate the initiative
Seeking Expression of Interest for the REDI Industry Fellowship Program 1 year full-time sponsored placement
A $200,000 WasteSorted e-Waste Grant from the Western Australian Government will be used to convert e-waste into useful end products, recover valuable metals and produce high value chemicals, thanks to our innovative Oxidative Hydrothermal Dissolution technology.
Epichem will continue essential lab-based operations, following WA Health Department advice, with COVID-19 safety protocols in place.
Thank you to the Australian Trade and Investment Commission (Austrade) for selecting Epichem’s 2020 story of spirit to showcase from Western Australia!
Congratulations to all winners of the inaugural Business News RISE Awards for WA Business of the Year. It was inspiring to see businesses innovate and thrive in the face of so many challenges in 2020. Epichem enjoyed attending the event held on 2 December at the Crown Ballroom.